GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Hangzhou AGS Medtech Co Ltd (SHSE:688581) » Definitions » ROE % Adjusted to Book Value

Hangzhou AGS Medtech Co (SHSE:688581) ROE % Adjusted to Book Value : 4.92% (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Hangzhou AGS Medtech Co ROE % Adjusted to Book Value?

Hangzhou AGS Medtech Co's ROE % for the quarter that ended in Mar. 2024 was 9.49%. Hangzhou AGS Medtech Co's PB Ratio for the quarter that ended in Mar. 2024 was 1.93. Hangzhou AGS Medtech Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was 4.92%.


Hangzhou AGS Medtech Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Hangzhou AGS Medtech Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hangzhou AGS Medtech Co ROE % Adjusted to Book Value Chart

Hangzhou AGS Medtech Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial - - - - 5.13

Hangzhou AGS Medtech Co Quarterly Data
Dec17 Dec18 Dec19 Jun20 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 4.19 3.89 4.17 4.92

Competitive Comparison of Hangzhou AGS Medtech Co's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Hangzhou AGS Medtech Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hangzhou AGS Medtech Co's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hangzhou AGS Medtech Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Hangzhou AGS Medtech Co's ROE % Adjusted to Book Value falls into.



Hangzhou AGS Medtech Co ROE % Adjusted to Book Value Calculation

Hangzhou AGS Medtech Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=16.78% / 3.27
=5.13%

Hangzhou AGS Medtech Co's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=9.49% / 1.93
=4.92%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hangzhou AGS Medtech Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Hangzhou AGS Medtech Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Hangzhou AGS Medtech Co (SHSE:688581) Business Description

Traded in Other Exchanges
N/A
Address
No. 6 Kangxin Road, Building 597, Building 5, Yuhang District, Zhejiang Province, Hangzhou, CHN, 311106
Hangzhou AGS Medtech Co Ltd is engaged in Research & Development, production, and sales of endoscopic minimally invasive diagnosis and treatment devices. The company upholds the core values of create, insist, share, and providing patients and clinicians with safer and more efficient minimally invasive endoscopic devices, helping patients reduce pain and medical costs.

Hangzhou AGS Medtech Co (SHSE:688581) Headlines

No Headlines